Cook Jocelynn L, Green Courtney R, de la Ronde Sandra, Dell Colleen A, Graves Lisa, Morgan Lisa, Ordean Alice, Ruiter James, Steeves Megan, Wong Suzanne
The Society for Obstetricians and Gynaecologists of Canada and the Department of Obstetrics and Gynaecology, University of Ottawa, Ottawa, ON.
The Society of Obstetricians and Gynaecologists of Canada, Ottawa, ON.
J Obstet Gynaecol Can. 2017 Oct;39(10):897-905. doi: 10.1016/j.jogc.2017.07.017.
Substance use during pregnancy has important implications for health care providers, policy makers, and can negatively impact a woman's health and the health of her children. Understanding trends, patterns of use and outcomes are critical to prevention campaigns, building awareness, and providing effective care. This review will discuss the current therapeutic approaches and recommendations for screening and patient management for substance use in pregnancy and during the postpartum period, and it is geared towards any care providers who care for patients or those who may care for patients who may be at risk for substance use during pregnancy.
孕期物质使用对医疗保健提供者、政策制定者具有重要影响，并且会对女性及其子女的健康产生负面影响。了解使用趋势、模式及后果对于预防宣传活动、增强意识以及提供有效护理至关重要。本综述将讨论孕期及产后物质使用的当前治疗方法以及筛查和患者管理的建议，其面向任何照顾患者或可能照顾孕期有物质使用风险患者的护理提供者。
